Dergiler / Turkish Thoracic Journal / 2021 / Cilt: 22 - Sayı: 1

Primary Immun Deficiency in Patients with Non-Cystic Fibrosis Bronchiectasis and Its Relationship with Clinical Parameters

Sayfa
37–44
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

These results emphasize the importance of immune function assessment in adult patients with NCFB.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:OBJECTIVE: Bronchiectasis is characterized by chronic respiratory infection.
📊
Temel Bulgular & Veri:The primary aim of this study was to determine the frequency of these neglected altered immune status by evaluating immunoglobulins, lymphocyte subsets, complement levels, and neutrophil function, and to assess its relationship with clinical parameters in adult patients with non-cystic fibrosis bronchiectasis (NCFB).MATERIAL AND METHODS: A total of 74 (30 men and 44 women with a mean age of 47±17 years) adult patients with stable NCFB were enrolled in this study.
💡
Sonuç & Katkı:These results emphasize the importance of immune function assessment in adult patients with NCFB.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

OBJECTIVE: Bronchiectasis is characterized by chronic respiratory infection. The role of immunodeficiency in this disease is poorly studied in relation to clinical indices. The primary aim of this study was to determine the frequency of these neglected altered immune status by evaluating immunoglobulins, lymphocyte subsets, complement levels, and neutrophil function, and to assess its relationship with clinical parameters in adult patients with non-cystic fibrosis bronchiectasis (NCFB).MATERIAL AND METHODS: A total of 74 (30 men and 44 women with a mean age of 47±17 years) adult patients with stable NCFB were enrolled in this study. The bronchiectasis severity index (BSI) and FACED (F:FEV1, A: Age, C: Chronic colonization, E: Extension, D: Dyspnea) scores were assessed. Peripheral blood samples were collected for the detection of total IgG, IgA, IgM, IgE, and IgG subclasses and C3 and C4 levels. The counts of CD3, CD4, CD8, CD19, CD16/56 expressing peripheral blood lymphocytes and neutrophil oxidative function were evaluated.RESULTS: In the study population, BSI and FACED severity index scores increased with longer duration of the disease (p=0.01 and p=0.040, respectively). Of the 74 patients, 27 (37%) showed humoral aberrations. The number of male patients were higher in this group (p=0.03). High serum total IgE levels were associated with high scores in BSI (moderate-severe group versus mild group, p=0.030). Patients with bronchiectasis demonstrated lower CD3+ T cell count, lower CD4+ T helper cell percentage, and lower CD4+ T cell count (p=0.031, p=0.030, p=0.029, respectively) than healthy subjects. A significant negative correlation was found between the percentage and count of CD16/56+ natural killer (NK) cells and the number of exacerbations within the past year (r=-0.230, p=0.049 and r=-0.264, p=0.023, respectively).CONCLUSION: Humoral aberrations in adult patients with NCFB were found to be frequent. IgE levels were related to high scores for disease severity indices. Furthermore, patients with low percentage and counts of NK cells had higher rates of exacerbations. These results emphasize the importance of immune function assessment in adult patients with NCFB.

🔖

Bu Makaleye Atıf Yap

BEKİR, M., AYDINER, E. K., YILDIZELİ, Ş. O., ÖĞÜLÜR, İ., KOCAKAYA, D., BARIŞ, S., ERYÜKSEL, E., ÖZER, A., CEYHAN, B. B. (2021). Primary Immun Deficiency in Patients with Non-Cystic Fibrosis Bronchiectasis and Its Relationship with Clinical Parameters. Turkish Thoracic Journal, Cilt: 22 - Sayı: 1, 37–44. https://ajindex.com/articles/417264

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Brower KS, Del Vecchio MT, Aronoff SC. The etiologies of nonCF bronchiectasis in childhood: A systematic review of 989 subjects. BMC Pediatr 2014
  2. 4 [Crossref] 2. Lee E, Shim JY, Kim HY, et al. Clinical characteristics and etiologies of bronchiectasis in Korean children: A multicenter retrospective study. Respir Med 2019
  3. [Crossref] 3. Pasteur MC, Helliwell SM, Houghton SJ, et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000
  4. [Crossref] 4. Touw CM, van de Ven AA, de Jong PA, et al. Detection of pulmonary complications in common variable immunodeficiency. Pediatr Allergy Immunol 2010
  5. [Crossref] 5. Costa-Carvalho BT, Grumach AS, Franco JL, et al. Attending to warning signs of primary immunodeficiency diseases across the range of clinical practice. J Clin Immunol 2014
  6. [Crossref] 6. Stead A, Douglas JG, Broadfoot CJ, et al. Humoral immunity and bronchiectasis. Clin Exp Immunol 2002
  7. [Crossref] 7. Maarschalk-Ellerbroek LJ, Hoepelman AI, van Montfrans JM, et al. The spectrum of disease manifestations in patients with common variable immunodeficiency disorders and partial antibody deficiency in a university hospital. J Clin Immunol 2012
  8. [Crossref] 8. Cereser L, De Carli M, d’Angelo P, et al. High-resolution computed tomography findings in humoral primary immunodeficiencies and correlation with pulmonary function tests. World J Radiol 2018
  9. [Crossref] 9. King P, Bennett-Wood V, Hutchinson P, et al. Bactericidal activity of neutrophils with reduced oxidative burst from adults with bronchiectasis. APMIS 2009
  10. [Crossref] 10. Mooney D, Edgar D, Einarsson G, et al. Chronic lung disease in common variable immune deficiency (CVID): A pathophysiological role for microbial and non-B cell immune factors. Crit Rev Microbiol 2017
  11. [Crossref] 11. King PT, Hutchinson P, Holmes PW, et al. Assessing immune function in adult bronchiectasis. Clin Exp Immunol 2006
  12. [Crossref] 12. Hill AT, Haworth CS, Aliberti S, et al. EMBARC/BRR definitions working group. Pulmonary exacerbation in adults with bronchiectasis: A consensus definition for clinical research. Eur Respir J 2017
  13. pii: 1700051. [Crossref] 13. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005
  14. [Crossref] 14. Costa JC, Machado JN, Ferreira C, et al. The Bronchiectasis Severity Index and FACED score for ass